Thanks to the continuing support of Floridians purchasing the “End Breast Cancer” specialty license plate and the Florida Breast Cancer Foundation’s (FBCF) network of breast cancer supporters, survivors, and activists fighting to end the suffering caused by breast cancer, we have invested over $10 million in dedicated funding for breast cancer education and research programs in the state of Florida.
On behalf of the Board and Staff of the Florida Breast Cancer Foundation (FBCF), we congratulate the 2023 Scientific Research Grant Recipients:
- H. Lee Moffitt Cancer Center & Research Institute, Dr. Jacob Kresovich: "Methylation-based aging predictors of anthracycline-related"
- H. Lee Moffitt Cancer Center & Research Institute, Dr. Aixa Soyano, "Sequential “first strike, second strike” therapies on HR+ HER2- MBC"
- University of Miami, Dr. Juan Pablo de Rivero Vaccari: "Inflammatory Responses in Radiosensitivity and Breast Cancer Prognosis Disparity"
- University of Central Florida, Dr. Eunkyung Lee: "Mediators of Disparity of Quality of Life in Hispanic Breast Cancer Survivors"
- Florida International University, Dr. Venkadesh Sarkari Nadar: "A novel, arsenic-containing anti-cancer drugs for triple-negative breast cancer"
- H. Lee Moffitt Cancer Center & Research Institute, Dr. Thordur Oskarsson: "Tetraspanin function in disseminated tumor cells of triple-negative breast cancer"
- University of South Florida, Dr. Libin Ye: "Regulation of Estrogen Receptor Ligands in TNBC-related GPR30 Signaling"
- University of Central Florida, Dr. Ratna Chakrabarti: "Function of PAINT long noncoding RNA in breast cancer"